[EN] HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL<br/>[FR] INHIBITEURS HÉTÉROCYCLIQUES DU CANAL SODIQUE
申请人:ZALICUS PHARMACEUTICALS LTD
公开号:WO2015130957A1
公开(公告)日:2015-09-03
The invention relates to compounds useful in treating conditions associated with voltage-gated ion channel function, particularly conditions associated with sodium channel activity. More specifically, the invention concerns heterocyclic compounds (e.g., compounds according to any of Formulas (l)-(ll l) or Compounds (1 )-(65) of Table 1 ) that are that are useful in treatment of conditions such as epilepsy, cancer, pain, migraine, Parkinson's Disease, mood disorders, schizophrenia, psychosis, tinnitus, amyotropic lateral sclerosis, glaucoma, ischaemia, spasticity disorders, obsessive compulsive disorder, restless leg syndrome and Tourette syndrome.
该发明涉及与电压门控离子通道功能相关的化合物,特别是与钠通道活性相关的病症。更具体地,该发明涉及杂环化合物(例如,符合任何一种公式(l)-(ll l)或表1的化合物(1)-(65)的化合物),这些化合物可用于治疗癫痫、癌症、疼痛、偏头痛、帕金森病、情绪障碍、精神分裂症、精神病、耳鸣、肌萎缩性侧索硬化、青光眼、缺血、痉挛性疾病、强迫症、不安腿综合征和抽动症等病症的治疗。